Discover the shocking statistics and impact of postpartum depression and psychosis. Find out how they affect millions of women globally.
Postpartum depression (PPD) and postpartum psychosis (PPP) are often overlooked but significant mental health conditions that impact a large number of women worldwide. PPD, affecting up to 20% of women, and PPP, impacting between 12 million and 352.3 million births globally, highlight the need for greater awareness and support for new mothers. The struggles faced by women dealing with these conditions can be isolating and overwhelming, making it essential for healthcare systems to prioritize screening and intervention programs.
Postpartum depression is characterized by feelings of extreme sadness, anxiety, and fatigue after childbirth, while postpartum psychosis is a rare but severe condition that can lead to hallucinations, delusions, and confusion. The societal stigma surrounding mental health issues often exacerbates the challenges faced by women experiencing these conditions, emphasizing the importance of open and compassionate discussions to reduce the burden of shame and guilt.
Despite the prevalence of PPD and PPP, many women continue to suffer in silence due to the lack of understanding and support available. By recognizing the signs and symptoms early on, healthcare providers and loved ones can offer the necessary assistance and resources to help mothers navigate this challenging period. It is vital to destigmatize mental health issues and encourage women to seek help without fear of judgment or isolation.
Postpartum depression (PPD) and postpartum psychosis (PPP) affect up to 20% of women and between 12 million and 352.3 million births globally, respectively.
The National Eligibility cum Entrance Test (NEET) is a crucial examination in India, determining admission to medical and dental colleges across the country ...
The presenter says he has suffered "dark thoughts" but discovered exercise helped lift his mood.
Experts say many displaced patients skip treatment due to various challenges, including shortage of appointments and medication and unfamiliarity with ...
Oxford University's department of psychiatry is testing the digital tool known as Petrushka, which it said would personalise antidepressant treatment. It uses ...
Oxford University's department of psychiatry is testing the digital tool known as Petrushka, which it said would personalise antidepressant treatment. It uses ...